New drugs for HDL-C disorders: the beginning
Date
2014
Authors
Duong, M.
Nicholls, S.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Current Medicinal Chemistry, 2014; 21(25):2947-2951
Statement of Responsibility
MyNgan Duong and Stephen J. Nicholls
Conference Name
Abstract
For more than 20 years there has been increasing interest in the development of novel therapies to raise levels of high-density lipoprotein cholesterol (HDL-C). However, well publicized failures of recent clinical trials of agents that raise HDL-C levels have stimulated considerable controversy with regard to the potential clinical utility of this therapeutic target. A number of classes of agents are currently under investigation with variable effects on HDL quantity and quality. These will be reviewed.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2016 Bentham Science Publishers